Develops RNA-targeting therapeutics for genetic diseases.
Dec 2025Revenue $3.50M/yrExpenses $56.1M/yr
No trendCash runway ≈ 3.0 years from Jun 2026
Figures by year
When will Camp4 Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $3.50M and expenses $56.1M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $3.50M | $56.1M | −$52.6M |
| Dec 2024 | $652K | $53.7M | −$53.1M |
| Dec 2023 | $350K | $52.2M | −$51.9M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.